The requirement of Artemis in double-strand break repair depends on the type of DNA damage.

Artemis is a recently identified factor involved in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. Here, we performed targeted disruption of the Artemis gene (ARTEMIS) in the human pre-B cell line Nalm-6. Unexpectedly, we found that cells lacking Artemis exhibit increased sensitivity to low doses, but not high doses, of ionizing radiation. We also show that ARTEMIS-deficient cells are hypersensitive to the topoisomerase II inhibitor etoposide, but to a much lesser extent than cells lacking DNA ligase IV, a critical component of NHEJ. Unlike DNA ligase IV-deficient cells, ARTEMIS-deficient cells were not hypersensitive to ICRF-193, a topoisomerase II inhibitor that does not stabilize topoisomerase II-DNA cleavable complexes. Collectively, our results suggest that Artemis only partially participates in the NHEJ pathway to repair DSBs in human somatic cells.

[1]  G. Iliakis,et al.  Marked dependence on growth state of backup pathways of NHEJ. , 2007, International journal of radiation oncology, biology, physics.

[2]  M. Wyatt,et al.  Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. , 2006, Chemical research in toxicology.

[3]  L. Povirk Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. , 2006, DNA repair.

[4]  H. Koyama,et al.  Simple one-week method to construct gene-targeting vectors: application to production of human knockout cell lines. , 2006, BioTechniques.

[5]  K. Schwarz,et al.  Making V(D)J rearrangement visible: quantification of recombination efficiency in real time at the single cell level. , 2006, Journal of immunological methods.

[6]  T. Date,et al.  53BP1 contributes to survival of cells irradiated with X‐ray during G1 without Ku70 or Artemis , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[7]  S. Soubeyrand,et al.  Artemis phosphorylated by DNA-dependent protein kinase associates preferentially with discrete regions of chromatin. , 2006, Journal of molecular biology.

[8]  A. Fischer,et al.  Cernunnos Interacts with the XRCC4·DNA-ligase IV Complex and Is Homologous to the Yeast Nonhomologous End-joining Factor Nej1* , 2006, Journal of Biological Chemistry.

[9]  S. Jackson,et al.  XLF Interacts with the XRCC4-DNA Ligase IV Complex to Promote DNA Nonhomologous End-Joining , 2006, Cell.

[10]  Yunmei Ma,et al.  The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. , 2005, DNA repair.

[11]  Yunmei Ma,et al.  Repair of Double-Strand DNA Breaks by the Human Nonhomologous DNA End Joining Pathway: The Iterative Processing Model , 2005, Cell cycle.

[12]  Yunmei Ma,et al.  Plenary Papers (356 articles) , 2005 .

[13]  L. Notarangelo,et al.  Damaging‐agent sensitivity of Artemis‐deficient cell lines , 2005, European journal of immunology.

[14]  A. Feeney,et al.  Targeted Disruption of the Artemis Murine Counterpart Results in SCID and Defective V(D)J Recombination That Is Partially Corrected with Bone Marrow Transplantation1 , 2005, The Journal of Immunology.

[15]  M. Lieber,et al.  Genetic Interactions between BLM and DNA Ligase IV in Human Cells* , 2004, Journal of Biological Chemistry.

[16]  Yunmei Ma,et al.  A biochemically defined system for mammalian nonhomologous DNA end joining. , 2004, Molecular cell.

[17]  H. Arakawa,et al.  DNA Cross-Link Repair Protein SNM1A Interacts with PIAS1 in Nuclear Focus Formation , 2004, Molecular and Cellular Biology.

[18]  Yunmei Ma,et al.  The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. , 2004, DNA repair.

[19]  H. Koyama,et al.  Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage. , 2004, Biochemical and biophysical research communications.

[20]  Yunmei Ma,et al.  Functional and biochemical dissection of the structure‐specific nuclease ARTEMIS , 2004, The EMBO journal.

[21]  Stephen P. Jackson,et al.  A means to a DNA end: the many roles of Ku , 2004, Nature Reviews Molecular Cell Biology.

[22]  H. Koyama,et al.  Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193 , 2003, Journal of Biological Chemistry.

[23]  George Iliakis,et al.  Biochemical evidence for Ku-independent backup pathways of NHEJ. , 2003, Nucleic acids research.

[24]  Yunmei Ma,et al.  Mechanism and regulation of human non-homologous DNA end-joining , 2003, Nature Reviews Molecular Cell Biology.

[25]  M. van der Burg,et al.  Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. , 2003, Blood.

[26]  K. Schwarz,et al.  The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants. , 2002, DNA repair.

[27]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[28]  S. Jackson,et al.  Sensing and repairing DNA double-strand breaks. , 2002, Carcinogenesis.

[29]  Yunmei Ma,et al.  Hairpin Opening and Overhang Processing by an Artemis/DNA-Dependent Protein Kinase Complex in Nonhomologous End Joining and V(D)J Recombination , 2002, Cell.

[30]  H. Koyama,et al.  DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: Implications for DNA double-strand break repair , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Essigmann,et al.  Mechanisms of resistance to cisplatin. , 2001, Mutation research.

[32]  H. Koyama,et al.  Decreased topoisomerase IIα expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells , 2001 .

[33]  A. Fischer,et al.  Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency , 2001, Cell.

[34]  J. Haber Partners and pathwaysrepairing a double-strand break. , 2000, Trends in genetics : TIG.

[35]  A. Fischer,et al.  A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome 10p. , 2000, Human molecular genetics.

[36]  N. Osheroff,et al.  A Novel Mechanism of Cell Killing by Anti-topoisomerase II Bisdioxopiperazines* , 2000, The Journal of Biological Chemistry.

[37]  B. Hill,et al.  Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds , 1999, British Journal of Cancer.

[38]  M. Leng,et al.  Interstrand cross-links of cisplatin induce striking distortions in DNA. , 1999, Journal of inorganic biochemistry.

[39]  C. Cordon-Cardo,et al.  Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Hoeijmakers,et al.  Molecular mechanisms of DNA double strand break repair. , 1998, Trends in cell biology.

[41]  K. Schwarz,et al.  DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. , 1998, Molecular cell.

[42]  T. Andoh,et al.  Catalytic inhibitors of DNA topoisomerase II. , 1998, Biochimica et biophysica acta.

[43]  M. Lieber,et al.  Requirement for an Interaction of XRCC4 with DNA Ligase IV for Wild-type V(D)J Recombination and DNA Double-strand Break Repairin Vivo * , 1998, The Journal of Biological Chemistry.

[44]  Y. Yamaguchi-Iwai,et al.  Homologous recombination and non‐homologous end‐joining pathways of DNA double‐strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells , 1998, The EMBO journal.

[45]  P. Jeggo,et al.  Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. , 1998, Immunity.

[46]  A. Fischer,et al.  A Human Severe Combined Immunodeficiency (SCID) Condition with Increased Sensitivity to Ionizing Radiations and Impaired V(D)J Rearrangements Defines a New DNA Recombination/Repair Deficiency , 1998, The Journal of experimental medicine.

[47]  G. Chu Double Strand Break Repair* , 1997, The Journal of Biological Chemistry.

[48]  W. Allan,et al.  Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II. , 1997, Biochemical pharmacology.

[49]  W. T. Beck,et al.  Antitopoisomerase drug action and resistance. , 1996, European journal of cancer.

[50]  Z. Wang,et al.  Differential control of transcription‐induced and overall DNA supercoiling by eukaryotic topoisomerases in vitro. , 1996, The EMBO journal.

[51]  J. Wang,et al.  Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Pinedo,et al.  Mechanism of action of antitumor drug etoposide: a review. , 1988, Journal of the National Cancer Institute.

[53]  B. Hill,et al.  Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agents , 1998, Cancer Chemotherapy and Pharmacology.

[54]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.